Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 11, 2024
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review
Safa Can Efil, Burak Bilgin, Furkan Ceylan, et al.
Journal of Clinical Medicine
|
January 11, 2025
Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer
Furkan Ceylan, Mirmehdi Mehdiyev, Didem Şener Dede, et al.
Expert Review of Anticancer Therapy
|
April 9, 2025
The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer
Furkan Ceylan, Safa Can Efil, Didem Şener Dede, et al.
Turkish Journal of Medical Sciences
|
July 21, 2025
Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer
Furkan Ceylan, Didem Şener Dede, Safa Can Efil, et al.
Scientific Reports
|
May 9, 2024
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
Murat Bardakci, Hilal Karakas, Dogan Bayram, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 15, 2020
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
Mutlu Hizal, Mehmet An Sendur, Hatime Arzu Yasar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
October 27, 2019
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
Hatime Arzu Yasar, Kadriye Bir Yucel, Cagatay Arslan, et al.
Journal of Clinical Medicine
|
February 27, 2026
Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study
Mehmet Cihan İcli, Deniz Can Guven, Arif Akyildiz, et al.
The Oncologist
|
March 16, 2026
Comparison of Six Cycles with Four Cycles of Chemotherapy and Atezolizumab in the First-Line Treatment of ES-SCLC; A Retrospective Multicenter Analysis
Halil Göksel Güzel, Derya Kıvrak Salim, Saadettin Kılıçkap, et al.
Cancers
|
January 25, 2025
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach
Hakan Şat Bozcuk, Leyla Sert, Muhammet Ali Kaplan, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 11, 2024
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review
Safa Can Efil, Burak Bilgin, Furkan Ceylan, et al.
Journal of Clinical Medicine
|
January 11, 2025
Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer
Furkan Ceylan, Mirmehdi Mehdiyev, Didem Şener Dede, et al.
Expert Review of Anticancer Therapy
|
April 9, 2025
The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer
Furkan Ceylan, Safa Can Efil, Didem Şener Dede, et al.
Turkish Journal of Medical Sciences
|
July 21, 2025
Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer
Furkan Ceylan, Didem Şener Dede, Safa Can Efil, et al.
Scientific Reports
|
May 9, 2024
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
Murat Bardakci, Hilal Karakas, Dogan Bayram, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 15, 2020
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
Mutlu Hizal, Mehmet An Sendur, Hatime Arzu Yasar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
October 27, 2019
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
Hatime Arzu Yasar, Kadriye Bir Yucel, Cagatay Arslan, et al.
Journal of Clinical Medicine
|
February 27, 2026
Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study
Mehmet Cihan İcli, Deniz Can Guven, Arif Akyildiz, et al.
The Oncologist
|
March 16, 2026
Comparison of Six Cycles with Four Cycles of Chemotherapy and Atezolizumab in the First-Line Treatment of ES-SCLC; A Retrospective Multicenter Analysis
Halil Göksel Güzel, Derya Kıvrak Salim, Saadettin Kılıçkap, et al.
Cancers
|
January 25, 2025
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach
Hakan Şat Bozcuk, Leyla Sert, Muhammet Ali Kaplan, et al.
Page
of 10